@xconomy.com 4 months ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 5 months ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@DrSeeboth 5 months ago
This #technology would probably also enable us to identify neurological and muscular gait disorders. #medicine #future #ML #wearables #DHPSP #MachineLearning https://twitter.com/dhpsp/status/1288670220366811138
@techcrunch.com 1 year ago
Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures